@article{513cf948325544c190ff5cab9d6358e3,
title = "Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19",
keywords = "COVID-19 Therapeutics, COVID-19 vaccines, Convalescent plasma (CP) therapy, SARS – CoV – 2, neutralizing antibodies",
author = "Razonable, {Raymund R.} and Peter Chen",
note = "Funding Information: This work was supported by R01HL155759 (PC), R01HL137076 (PC), and an intramural grant at Mayo Clinic (RR). Funding Information: Topic Editor RR received grants from Regeneron, Gilead, and Roche, for research purposes. Topic Editors PC received grants from Regeneron, Gilead, and Eli Lilly. ",
year = "2022",
month = may,
day = "31",
doi = "10.3389/fimmu.2022.938069",
language = "English (US)",
volume = "13",
journal = "Frontiers in immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
}